Hypothalamic Treatment Shows Promise for Some Neurological Patients
Researchers studied the effects of a treatment called Liposom Forte, which contains hypothalamic phospholipids, in three patients with different neurological disorders.
This hub covers epilepsy comorbidities, which are the other conditions that often show up alongside seizures (like ADHD, anxiety, depression, autism, and sleep issues). Plain-language research takeaways for families.
Often both. Shared brain networks, stress, sleep disruption, and medication effects can all contribute.
Track timing: New symptoms after med changes or dose increases may point to side effects.
If school is hard, attention/memory changes, or thereβs concern about learning, yes, it can guide supports.
Sometimes. Improving sleep and stress can reduce seizure susceptibility in some people.
Researchers studied the effects of a treatment called Liposom Forte, which contains hypothalamic phospholipids, in three patients with different neurological disorders.
This study looked at the health-related quality of life (HRQOL) in children with epilepsy in Addis Ababa, Ethiopia.
Researchers studied the clinical and genetic features of intellectual disability in 959 children at Oulu University Hospital in Finland over five years, from 2017 to 2021.
Researchers studied the long-term safety of stopping antiseizure medications (ASMs) in newborns who had experienced acute provoked seizures.
This study looked at how early clinical signs and EEG (brain wave) patterns relate to the outcomes of children with genetic epilepsies.
Researchers studied the effects of meditation on people with epilepsy to see how it might help manage the condition.
This study looked at two tools used to evaluate the quality of research on epilepsy, specifically focusing on studies that examine psychiatric conditions in people with epilepsy.
A recent study looked at how depression is diagnosed and treated in adults with epilepsy in China.
Researchers studied the development of clinical practice guidelines (CPGs) and consensus-based recommendations (CBRs) for managing epilepsy.